Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2BTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3MPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PPARGSLC6A2SLC6A3SLC6A4SMOTYK2pol
The experimentally established mechanism targets of Maleic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD known ✓ | O00329 | 1/20 | 0.36 |
| ▸ | PIK3R2 known ✓ | O00459 | 1/20 | 0.36 |
| ▸ | PIK3CA known ✓ | P42336 | 1/20 | 0.36 |
| ▸ | PIK3CB known ✓ | P42338 | 1/20 | 0.36 |
| ▸ | PIK3CG known ✓ | P48736 | 1/20 | 0.36 |
| ▸ | PIK3R5 known ✓ | Q8WYR1 | 1/20 | 0.36 |
| ▸ | PIK3R3 known ✓ | Q92569 | 1/20 | 0.36 |
| ▸ | ACKR3 | P25106 | 2/20 | 0.40 |
| ▸ | HCRTR1 | O43613 | 6/20 | 0.36 |
| ▸ | HCRTR2 | O43614 | 6/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 3/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.34 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL7400191 | 1.00 | ACKR3 (0.40) | ACKR3HCRTR1HCRTR2KMT2AGSK3B | |
| SCHEMBL7397803 | 0.96 | ACKR3 (0.42) | ACKR3HCRTR1HCRTR2KMT2AGSK3B | |
| Maleic Acid SCHEMBL7399487 | 0.86 | KDM1A (0.38) | ACKR3HCRTR1HCRTR2KMT2A | |
| SCHEMBL7403466 | 0.85 | ACKR3 (0.40) | ACKR3HCRTR1HCRTR2KMT2ACARM1 | |
| Fumaric Acid SCHEMBL7399492 | 0.85 | HCRTR1 (0.33) | ACKR3HCRTR1HCRTR2KMT2ABCHE | |
| Maleic Acid SCHEMBL7399489 | 0.85 | HCRTR1 (0.33) | ACKR3HCRTR1HCRTR2KMT2ABCHE | |
| Maleic Acid SCHEMBL7392185 | 0.85 | HCRTR1 (0.36) | HCRTR1HCRTR2KMT2APIK3CDPIK3CG | |
| Fumaric Acid SCHEMBL7392191 | 0.85 | HCRTR1 (0.36) | HCRTR1HCRTR2KMT2APIK3CDPIK3CG | |
| Fumaric Acid SCHEMBL7398829 | 0.84 | SMN1; SMN2 (0.35) | ACKR3HCRTR1HCRTR2KMT2A | |
| Maleic Acid SCHEMBL7398825 | 0.84 | SMN1; SMN2 (0.35) | ACKR3HCRTR1HCRTR2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0972773-A1 | 2-Oxadiazolyl- or 2-thiadiazolyl-phenylcarbamate and -phenylurea derivatives, their preparation and their use as intermediates | GLAXO GROUP LIMITED (GB) | 2000-01-19 | — | — | EP | disclosed |
| EP-0640081-B1 | SUBSTITUTED PHENYLCARBAMATES AND PHENYLUREAS, THEIR PREPARATION AND THEIR USE AS 5-HT4 ANTAGONISTS | GLAXO GROUP LTD (GB) | 2000-01-12 | — | — | EP | disclosed |
| US-5618827-A | TREATING GASTROINTESTINAL, URINARY, CARDIOVASCULAR, CENTRAL NERVOUS SYTEM DISORDERS | GLAXO GROUP LIMITED (GB) | 1997-04-08 | — | — | US | disclosed |
| EP-0640081-A1 | SUBSTITUTED PHENYLCARBAMATES AND PHENYLUREAS, THEIR PREPARATION AND THEIR USE AS 5-HT ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 1995-03-01 | — | — | EP | disclosed |
| WO-1993020071-A1 | SUBSTITUTED PHENYLCARBAMATES AND PHENYLUREAS, THEIR PREPARATION AND THEIR USE AS 5-HT ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 1993-10-14 | — | — | WO | disclosed |